These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users. Scott LA; Roxburgh A; Bruno R; Matthews A; Burns L Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716 [TBL] [Abstract][Full Text] [Related]
26. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users. Roberts CA; Fairclough SH; McGlone FP; Fisk JE; Montgomery C Exp Clin Psychopharmacol; 2013 Dec; 21(6):507-15. PubMed ID: 24080019 [TBL] [Abstract][Full Text] [Related]
27. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users. Fisk JE; Montgomery C; Murphy PN Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632 [TBL] [Abstract][Full Text] [Related]
28. Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task. Roberts GM; Nestor L; Garavan H Brain Res; 2009 Oct; 1292():71-81. PubMed ID: 19631624 [TBL] [Abstract][Full Text] [Related]
29. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. Parrott AC J Psychopharmacol; 2005 Jan; 19(1):71-83. PubMed ID: 15671132 [TBL] [Abstract][Full Text] [Related]
30. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences? Hoshi R; Pratt H; Mehta S; Bond AJ; Curran HV J Psychopharmacol; 2006 Mar; 20(2):291-301. PubMed ID: 16510487 [TBL] [Abstract][Full Text] [Related]
31. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use. Bedi G; Van Dam NT; Redman J J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429 [TBL] [Abstract][Full Text] [Related]
33. The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic? Fisk JE; Montgomery C; Wareing M; Murphy PN Hum Psychopharmacol; 2006 Aug; 21(6):355-66. PubMed ID: 16915582 [TBL] [Abstract][Full Text] [Related]
34. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms? Guillot C J Psychoactive Drugs; 2007 Mar; 39(1):31-9. PubMed ID: 17523583 [TBL] [Abstract][Full Text] [Related]
35. Executive function in abstinent MDMA ('ecstasy') users. Zakzanis KK; Young DA Med Sci Monit; 2001; 7(6):1292-8. PubMed ID: 11687745 [TBL] [Abstract][Full Text] [Related]
36. Investigating the role of serotonin in visual orientation processing using an 'ecstasy' (MDMA)-based research model. Dickson C; Bruno R; Brown J Neuropsychobiology; 2009; 60(3-4):204-12. PubMed ID: 19893337 [TBL] [Abstract][Full Text] [Related]
37. Mental disorders in current and former heavy ecstasy (MDMA) users. Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720 [TBL] [Abstract][Full Text] [Related]
38. Alcohol use and risk taking among regular ecstasy users. Breen C; Degenhardt L; Kinner S; Bruno R; Jenkinson R; Matthews A; Newman J Subst Use Misuse; 2006; 41(8):1095-109. PubMed ID: 16798678 [TBL] [Abstract][Full Text] [Related]
39. The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA. Wetherell MA; Atherton K; Grainger J; Brosnan R; Scholey AB Hum Psychopharmacol; 2012 Mar; 27(2):167-76. PubMed ID: 22389081 [TBL] [Abstract][Full Text] [Related]
40. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. Carhart-Harris RL; Nutt DJ; Munafò M; Wilson SJ J Psychopharmacol; 2009 May; 23(3):249-57. PubMed ID: 18562419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]